Zhiting Peng

Dr. Zhiting Peng

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2022 in ACS Sensors
Verified
Journal Article
Closed access
MLMan Shek Li
Man Shek Li
William Ho Lam WongWilliam Ho Lam Wong
William Ho Lam Wong
YIYan Lam Ip
Yan Lam Ip
ZPZhiting Peng
Zhiting Peng
RYRachel Yiu
Rachel Yiu
Yau Kei ChanYau Kei Chan
Yau Kei Chan

25 May 2023 in Nanoscale
Verified
Journal Article
Closed access
PDF file
ZPZhiting Peng
Zhiting Peng
YZYage Zhang
Yage Zhang
CCChin Long Ronald Choi
Chin Long Ronald Choi
PZPengcheng Zhang
Pengcheng Zhang
TWTianzhun Wu
Tianzhun Wu
Yau Kei ChanYau Kei Chan
Yau Kei Chan
Experience the future of lithography with roller nano imprinting, the revolutionary technology that will revolutionize our production processes.

9 October 2020 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
ZPZhiting Peng
Zhiting Peng
YCYan Chen
Yan Chen
TWTianzhun Wu
Tianzhun Wu

30 November 2025 in Micromachines
Verified
Journal Article
Open access
PDF file
TGTianyi Gao
Tianyi Gao
JHJunhao HAO
Junhao HAO
HMHeather Mak
Heather Mak
ZPZhiting Peng
Zhiting Peng
JWJing Wu
Jing Wu
Yau Kei ChanYau Kei Chan
Yau Kei Chan
Glaucoma is the leading cause of irreversible blindness, primarily characterized by retinal ganglion cell (RGC) loss and optic nerve damage due to abnormal alterations in intraocular pressure (IOP). While in vivo models provide valuable insights into its pathophysiology, they face limitations in controlling biomechanical parameters and long-term IOP monitoring. In vitro models offer greater experimental control but often lack the complexity of the ocular microenvironment, limiting their physiological relevance. To better understand RGC degeneration from a biomechanical perspective, advancements are needed to improve these models, including precise pressure manipulation and more realistic cell culture conditions. This review summarizes current in vitro approaches for studying pressure-induced RGC degeneration and explores the potential of microfluidic technologies to enhance model fidelity. Incorporating microfluidic technologies holds promise for creating more physiologically relevant models, potentially advancing our understanding of IOP-related RGC degeneration from biomechanical perspectives.

16 October 2024 in Chemosensors
Verified
Journal Article
Open access
PDF file
YHYUN HUI
YUN HUI
WKWeijun Kong
Weijun Kong
SWShu Weiliang
Shu Weiliang
ZPZhiting Peng
Zhiting Peng
FSFengshan Shen
Fengshan Shen
Xue-Feng YuXue-Feng Yu
Xue-Feng Yu
The measurement of cardiac troponin I (cTnI) is of vital importance for the early diagnosis of acute myocardial infarction. In this study, an enhanced electrochemiluminescent immunoassay for the highly sensitive and precise determination of cTnI was reported. A biomimetic chip with nepenthes peristome surface microstructures to achieve single-layer microbead arrays and integrated microelectrode arrays (MEAs) for ECL detection was microfabricated. Ru@SiO2 nanoparticles were prepared as signal amplificators labeling immunomagnetic beads. Dendrimer-encapsulated platinum nanoparticles (Pt DENs) were electrochemically modified on ITO MEAs. The resulting Pt DEN-modified ITO MEAs preserved good optical transparency and exhibited an approximately 20-fold ECL signal amplification compared to that obtained from bare ITO. The method made full use of the biomimetic chip with Pt DENs to develop single-layer immunomagnetic bead arrays with increasingly catalyzed electrochemical oxidation of the [Ru(bpy)3]2+–TPA system. Consequently, a limit of detection calculated as 0.38 pg/mL (S/N = 3) was obtained with excellent selectivity, demonstrating significant potential for the detection of cTnI in clinical diagnostics.